Immunoreactivity for bcl-2 protein in malignant mesothelioma and non-neoplastic mesothelium
- 1 July 1994
- journal article
- Published by Springer Nature in Virchows Archiv
- Vol. 424 (6) , 631-634
- https://doi.org/10.1007/bf01069743
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- bcl-2 Protein in Non-Small-Cell Lung CarcinomaNew England Journal of Medicine, 1993
- bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell deathCell, 1993
- BCL‐2 expression in adult and embryonic non‐haematopoietic tissuesThe Journal of Pathology, 1993
- Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinomaHuman Pathology, 1993
- Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sectionsThe Journal of Pathology, 1992
- Immunoreactivity for the β chain of the platelet‐derived growth factor receptor in malignant mesothelioma and non‐neoplastic mesotheliumThe Journal of Pathology, 1992
- BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.Proceedings of the National Academy of Sciences, 1991
- Immunohistochemical distribution patterns of epidermal growth factor receptor in malignant mesothelioma and non-neoplastic mesotheliumVirchows Archiv, 1991
- Cytogenetic analysis of malignant mesotheliomaCancer Genetics and Cytogenetics, 1990
- Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocationCell, 1986